Bristol Myers Squibb (BMS) has recognised Singapore as its new Pan Asia Cluster (PAC) hub, supported by the Singapore Economic Development Board, as part of its regional operations.

• Regional Scope: The hub brings together operations across Hong Kong and Macau, Taiwan, Singapore, Malaysia, Thailand, Vietnam, Indonesia and the Philippines.
• Operational Focus: The PAC hub is intended to strengthen regional capabilities, support talent development and expand strategic partnerships.
• Research Activities: BMS currently has more than 60 clinical trials across the PAC region, with five new trials targeted to begin in Singapore by the end of 2026.

This summary is based on a news article published by BioSpectrum Asia.

Image for illustrative purposes only. Source: Canva.

About Ehub365

For Corporate Clients, ehub365 division delivers critical insights into the ASEAN medical sector, covering investments, new services, and practitioner news. 

A member of 365Asia. Our additional group services are Health365, 365Asia, 健康365, 365Sehat, and 365MEC.